Leukaemia cutis and leukaemic vasculitis

被引:55
作者
Paydas, S [1 ]
Zorludemir, S
机构
[1] Cukurova Univ, Fac Med, Dept Oncol, TR-01330 Adana, Turkey
[2] Cukurova Univ, Fac Med, Dept Pathol, TR-01330 Adana, Turkey
关键词
fibrinoid necrosis; haematopoietic neoplasia; leukaemia cutis; leukaemic vasculitis; prognosis;
D O I
10.1046/j.1365-2133.2000.03774.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Leukaemia cutis (LC) and leukaemic vasculitis (LV) are uncommon but important features of haematological malignancy. Objectives We aimed to evaluate clinicopathological features of a series of such cases. Methods Thirty-four patients with LC were studied. Nineteen had acute myeloblastic leukaemia, six had acute lymphoblastic leukaemia, three had myelodysplastic syndrome-refractory anaemia with excess blast in transformation, three had non-Hodgkin's lymphoma in leukaemic phase, two had chronic lymphocytic leukaemia and one had multiple myeloma. Results Cutaneous lesions were widely dispersed in 15 patients, but were restricted to the extremities in eight patients. In other patients lesions were localized on the face, hands and feet. Cutaneous lesions were generally erythematous, maculopapular, squamous, nodular, haemorrhagic or necrotic. Two localizations were very interesting: in one case, lesions were confined to the site of previous varicella zoster virus infection; in the other case, leukaemic infiltration occurred within a lesion of cutaneous leishmaniasis. All of the patients had high white blood cell count and/or other findings of high tumour burden. Vasculitis with leukaemic cell infiltration (LV) was detected in 24 patients, and was high-grade LV in 16 patients. Patients with high-grade LV tended to have a higher white blood cell count and other findings associated with an aggressive clinical course compared with patients not having LV. Thirteen patients with LV died within 1 month but five patients lived more than 1 year. Conclusions LC, and especially LV, is generally an indicator of poor prognosis. Its pathogenesis must be evaluated further with additional studies, including adhesion molecules, angiogenic factors and other biological parameters.
引用
收藏
页码:773 / 779
页数:7
相关论文
共 30 条
  • [1] ARROWSMITH ER, 1999, WINTROBES CLIN HEMAT, V2, P2033
  • [2] LEUKEMIA-CUTIS IN ACUTE MYELOMONOCYTIC LEUKEMIA - PREFERENTIAL LOCALIZATION IN A RECENT HICKMAN CATHETER SCAR
    BADEN, TJ
    GAMMON, WR
    [J]. ARCHIVES OF DERMATOLOGY, 1987, 123 (01) : 88 - 90
  • [3] BAER MR, 1989, CANCER-AM CANCER SOC, V63, P2192, DOI 10.1002/1097-0142(19890601)63:11<2192::AID-CNCR2820631122>3.0.CO
  • [4] 2-R
  • [5] Bahadoran P, 1996, ANN DERMATOL VENER, V123, P471
  • [6] LEUKEMIA CUTIS MASQUERADING AS GUTTATE PSORIASIS
    BERGER, BJ
    GROSS, PR
    DANIELS, RB
    LANKTON, BB
    [J]. ARCHIVES OF DERMATOLOGY, 1973, 108 (03) : 416 - 418
  • [7] Braverman IM, 1981, SKIN SIGNS SYSTEMIC, P179
  • [8] LEUKEMIA CUTIS - A HISTOPATHOLOGIC STUDY OF 42 CASES
    BUECHNER, SA
    LI, CY
    SU, WPD
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1985, 7 (02) : 109 - 119
  • [9] Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from cancer and leukemia group B 8461
    Byrd, JC
    Weiss, RB
    Arthur, DC
    Lawrence, D
    Baer, MR
    Davey, F
    Trikha, ES
    Carroll, AJ
    Tantravahi, R
    Qumsiyeh, M
    Patil, SR
    Moore, JO
    Mayer, RJ
    Schiffer, CA
    Bloomfield, CD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 466 - 475
  • [10] CERRONI L, 1995, CANCER, V76, P26, DOI 10.1002/1097-0142(19950701)76:1<26::AID-CNCR2820760105>3.0.CO